All Industry News articles – Page 5
-
NewsWHO warns of dearth of new antibiotics, especially those targeting drug-resistant pathogens
A review from WHO on the number of new antibiotics currently in the pipeline shows that just 12 new antibiotics have entered the market in the five years from 2017-21.
-
NewsIntellifoods Labs, LLC teams with Mason scientists to cut food bacterial contamination detection time
Mason Associate Professor of Infectious Diseases and Microbiology, Ramin M Hakami has received $35,000 in grants from Intellifoods Labs, LLC to continue examining methods to reduce the time to detect the presence of bacteria in food samples.
-
![PET depolymerization reactor - CrÇdit photo Carbios[2][15]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/6/5/8/1658_petdepolymerizationreactorcrcditphotocarbios215_545583.jpg)
NewsFashion company joins fibre-to-fibre consortium founded by Carbios, On, Patagonia, PUMA and Salomon
Carbios, a pioneer of biological technologies for reinventing the life cycle of plastics and textiles, has signed an agreement with fashion company PVH Corp to join its fibre-to-fibre consortium founded with On, Patagonia, PUMA, and Salomon1.
-
NewsThree new appointments announced at AOAC International
Dr Katerina Mastovska has been named Deputy Executive Director and Chief Science Officer with AOAC International.
-
NewsBiomedical institutions agree on a set of open science practices to monitor
Eighty stakeholders from twenty major biomedical research institutions across the globe have agreed upon a list of 19 open science practices to be implemented and monitored.
-
NewsThe wait is over - AMI launches its new Jobs Board!
Applied Microbiology International is excited to announce the launch of its new Jobs Board.
-
NewsScientists create computer simulation based on digital microbes
Researchers at University of Galway associated with APC Microbiome Ireland, a world-leading SFI Research Centre, have created a resource of over 7,000 digital microbes – enabling computer simulations of how drug treatments work and how patients may respond. The resource is a milestone in scientific understanding of human response to ...
-
News Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project
Vésale Bioscience has announced it has received €1.8M in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project, a phagogram using artificial intelligence that enables decentralized diagnostics and personalized treatment.
-
NewsGeneral Biomics and The Jackson Laboratory announce intellectual property licensing agreement
General Biomics, Inc. and The Jackson Laboratory (JAX) have announced an expansive and exclusive intellectual property licensing agreement across six areas of human health.
-
NewsUS approves world’s first vaccine to protect honey bees
The world’s first vaccine for honey bees has been approved by authorities in the US.
-
NewsGamechanging project could propel anti-microbial peptides into forefront of AMR battle
Experts from the University of Huddersfield have teamed up with an international consortium of partners for a four-year research project that aims to develop a new method for the commercial production of anti-microbial peptides (AMPs).
-
NewsApplied Microbiology International announces plans for new open access journal, Sustainable Microbiology
Applied Microbiology International has announced that it will soon be launching a new open access journal, Sustainable Microbiology. It will be the first new journal launched by the society since Microbial Biotechnology in 2008 and will be published in partnership with Oxford University Press. Sustainable Microbiology is ...
-
NewsApplied Microbiology International launches new corporate membership programme packed with benefits
Applied Microbiology International (AMI) is delighted to launch its corporate membership programme, with a packed list of benefits and opportunities to fit the needs of any organisation.
-
-
NewsVaccine for Lyme disease one step closer with promising six-month results
A vaccine for Lyme disease is one step closer after Pfizer Inc and Valneva SE reported positive results in their antibody persistence data six months after completing a three-dose or two-dose schdule in children and adults with vaccine candidate VLA15.
-
NewsNew £1.7m containment facility will help prepare for future pandemics
A £1.7m laboratory building which will investigate infectious diseases has opened at the University of Warwick – helping to tackle some of the most globally important human diseases and prepare for pandemics of the future.
-
NewsStudy of simple acoziborole regime raises hope for elimination of sleeping sickness in Africa
The Drugs for Neglected Diseases initiative (DNDi) and Sanofi have announced treatment success rates of up to 95% from a Phase II/III study investigating the safety and efficacy of single-dose acoziborole, a potentially transformative investigational treatment for sleeping sickness.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
-
CareersA day in the life of a dairy microbiome field scientist
My role with California-based microbial solutions company Native Microbials takes me from the lab to the heart of the herd